PHASE-I TRIAL OF DIPYRIDAMOLE WITH 5-FLUOROURACIL AND FOLINIC ACID

被引：0
|
作者：
BUDD, GT
JAYARAJ, A
GRABOWSKI, D
ADELSTEIN, D
BAUER, L
BOYETT, J
BUKOWSKI, R
MURTHY, S
WEICK, J
机构：
[1] CLEVELAND CLIN FDN,CLEVELAND,OH 44195
[2] BOEHRINGER INGLEHEIM PHARMACEUT,RIDGEFIELD,CT
来源：
CANCER RESEARCH | 1990年 / 50卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7206 / 7211
页数：6
相关论文
共 50 条
  • [31] FOLINIC ACID DOES IMPROVE 5-FLUOROURACIL ACTIVITY INVIVO - RESULTS OF A PHASE-III STUDY COMPARING 5-FLUOROURACIL TO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLON CANCER-PATIENTS
    BOBBIOPALLAVICINI, E
    PORTA, C
    MORONI, M
    SPAGHI, A
    CASAGRANDA, I
    NASTASI, G
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (01) : 52 - 55
  • [32] A PHASE-I TRIAL OF INTERFERON ALPHA-2B WITH FOLINIC ACID AND 5-FLUOROURACIL ADMINISTERED BY 4-HOUR INFUSION IN METASTATIC COLORECTAL-CARCINOMA
    KREUSER, ED
    HILGENFELD, RU
    MATTHIAS, M
    HOKSCH, B
    BOEWER, C
    OLDENKOTT, B
    KNAUF, WU
    BOESELANDGRAF, J
    SCHALHORN, A
    ZEITZ, M
    THIEL, E
    SEMINARS IN ONCOLOGY, 1992, 19 (02) : 197 - 203
  • [33] Phase I trial of gemcitabine (Gemzar®, 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer
    Oettle, H
    Pelzer, U
    Hochmuth, K
    Diebold, T
    Langrehr, J
    Schmidt, CA
    Arning, M
    Vogl, TJ
    Neuhaus, P
    Huhn, D
    Riess, H
    ANTI-CANCER DRUGS, 1999, 10 (08) : 699 - 704
  • [34] 5-FLUOROURACIL MONOTHERAPY VERSUS FOLINIC ACID AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - RESULTS OF A RANDOMIZED TRIAL
    STEINKE, B
    GUNTHER, E
    HIRSCHMANN, W
    SONDERN, W
    KONICZECK, KH
    WANDER, HE
    NATT, F
    WAGNER, T
    HINRICHS, HF
    ROTH, W
    ONKOLOGIE, 1993, 16 (04): : 252 - 259
  • [35] PHASE-II TRIAL OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FINE, S
    ERLICHMAN, C
    KAIZER, L
    WARR, D
    GADALLA, T
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) : 205 - 209
  • [36] PHASE I/II TRIAL OF DIPYRIDAMOLE, 5-FLUOROURACIL, LEUKOVORIN, AND MITOXANTRONE IN METASTATIC BREAST-CANCER
    BUDD, GT
    HERZOG, P
    BUKOWSKI, RM
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 283 - 287
  • [37] CLINICAL PHARMACOKINETICS OF 5-FLUOROURACIL - INFLUENCE OF THE BIOMODULATING AGENTS INTERFERON, DIPYRIDAMOLE AND FOLINIC ACID ALONE AND IN COMBINATION
    CZEJKA, MJ
    JAGER, W
    SCHULLER, J
    FOGL, U
    WEISS, C
    SCHERNTHANER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (03): : 387 - 390
  • [38] INTERFERON ALPHA-2B, 5-FLUOROURACIL, AND FOLINIC ACID COMBINATION THERAPY IN ADVANCED COLORECTAL-CANCER - PRELIMINARY-RESULTS OF A PHASE-I/II TRIAL
    SCHMOLL, HJ
    KOHNEWOMPNER, CH
    HIDDEMANN, W
    KNIPP, H
    WILKE, H
    BODENSTEIN, H
    SCHOFFSKI, P
    BOKEMEYER, C
    LOHRMANN, HP
    PREISS, J
    KAUFER, C
    FISCHER, JT
    BALLEISEN, L
    URBANITZ, D
    HARSTRICK, A
    HILL, H
    SEMINARS IN ONCOLOGY, 1992, 19 (02) : 191 - 196
  • [39] A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer
    Garufi, C
    Levi, F
    Aschelter, AM
    Pace, R
    Giunta, S
    Nistico, C
    Galla, DAP
    Silecchia, GF
    Franchi, F
    Narduzzi, C
    Terzoli, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) : 1566 - 1571
  • [40] PHASE-I EVALUATION OF SPIROGERMANIUM AND 5-FLUOROURACIL IN COLORECTAL-CARCINOMA
    WILLIAMSON, SK
    SLAVIK, M
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 49 - 52
12345